CADL
CADL
US1374041093
Candel Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
48.177.000 33.371.000
44.4%
Operating Income -48.177.000 -33.371.000
44.4%
Pretax Income -38.182.000 -55.177.000
30.8%
Net Income Common Stockholders -38.182.000 -55.177.000
30.8%
-- --
--
-- --
--
ende